Clinical Trials
7 trialsNCT04637009 2024-08-02
A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms
Astex Pharmaceuticals, Inc.
Phase 1 Terminated
NCT01014546 2022-07-22
Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis
Roswell Park Cancer Institute
Phase 1 Terminated
NCT00004239 2016-07-04
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
Alliance for Clinical Trials in Oncology
Phase 1 Terminated
NCT00595829 2015-08-21
A Phase 1 Study of XL019 in Adults With Polycythemia Vera
Exelixis
Phase 1 Terminated
NCT01291784 2014-12-08
Anti-TGF-beta Therapy in Patients With Myelofibrosis
Icahn School of Medicine at Mount Sinai
Phase 1 Terminated
NCT00522574 2011-04-05
A Safety Study of XL019 in Adults With Myelofibrosis
Exelixis
Phase 1 Terminated
NCT00004058 2010-01-26
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Rutgers, The State University of New Jersey
Phase 1 Terminated